• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

21世纪的根治性前列腺切除术——局限性和局部进展性前列腺癌的金标准。

Radical prostatectomy in the 21st century - the gold standard for localized and locally advanced prostate cancer.

作者信息

Schostak M, Miller K, Schrader M

机构信息

Department of Urology, Charité Universitätsmedizin Berlin, Berlin , Germany.

出版信息

Front Radiat Ther Oncol. 2008;41:7-14. doi: 10.1159/000139873.

DOI:10.1159/000139873
PMID:18544980
Abstract

Radical prostatectomy for treatment of prostate cancer is a technically sophisticated operation. Simpler therapies have therefore been developed in the course of decades. The decisive advantage of a radical operation is the chance of a cure with minimal collateral damage. It is the only approach that enables precise tumor staging. The 10-year progression-free survival probability is approximately 85% for a localized tumor with negative resection margins. This high cure rate is unsurpassed by competitive treatment modalities. Nowadays, experienced surgeons achieve excellent functional results (for example, recovery of continence and erectile function) with minimum morbidity. Even in the locally advanced stage, results are very good compared to those obtained with other treatment modalities. Pathological staging enables stratified adjuvant therapy based on concrete information. The overall prognosis can thus be significantly improved.

摘要

根治性前列腺切除术治疗前列腺癌是一项技术复杂的手术。因此,在几十年间已开发出更简单的治疗方法。根治性手术的决定性优势在于有机会以最小的附带损害实现治愈。它是唯一能够进行精确肿瘤分期的方法。对于切缘阴性的局限性肿瘤,10年无进展生存率约为85%。这种高治愈率是其他竞争性治疗方式无法比拟的。如今,经验丰富的外科医生能以最低的发病率取得出色的功能结果(例如,恢复控尿和勃起功能)。即使在局部晚期,与其他治疗方式相比,效果也非常好。病理分期能够基于具体信息进行分层辅助治疗。从而可显著改善总体预后。

相似文献

1
Radical prostatectomy in the 21st century - the gold standard for localized and locally advanced prostate cancer.21世纪的根治性前列腺切除术——局限性和局部进展性前列腺癌的金标准。
Front Radiat Ther Oncol. 2008;41:7-14. doi: 10.1159/000139873.
2
Enhancing the efficacy of radical prostatectomy in locally advanced prostate cancer.提高局部晚期前列腺癌根治性前列腺切除术的疗效。
Urol Int. 1998;60 Suppl 2:2-10; discussion 35. doi: 10.1159/000056545.
3
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.辅助治疗初治患者根治性前列腺切除术后切缘阳性对前列腺特异抗原失败的影响。
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.
4
[The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].[采用根治性前列腺切除术或放射疗法治疗局部晚期(T3期)前列腺癌。综述]
Tijdschr Gerontol Geriatr. 1998 Apr;29(2):74-9.
5
[Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up].[根治性前列腺切除术作为局部晚期前列腺癌(T3a)的单一疗法:12年随访]
Arch Esp Urol. 2004 Sep;57(7):679-92.
6
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.根治性前列腺切除术治疗高危或极高危前列腺癌的肿瘤学和功能学结局:当前 NCCN®指南的欧洲验证。
J Urol. 2017 Aug;198(2):354-361. doi: 10.1016/j.juro.2017.02.070. Epub 2017 Feb 16.
7
Feasibility of minimally invasive radical prostatectomy in prostate cancer patients with high prostate-specific antigen: feasibility and 1-year outcomes.高前列腺特异性抗原前列腺癌患者微创根治性前列腺切除术的可行性:可行性和 1 年结果。
Int J Urol. 2012 Oct;19(10):923-7. doi: 10.1111/j.1442-2042.2012.03068.x. Epub 2012 Jul 4.
8
Is radical prostatectomy a viable therapeutic option in clinically locally advanced (cT3) prostate cancer?根治性前列腺切除术在临床局部进展期(cT3)前列腺癌中是否可行的治疗选择?
BJU Int. 2010 Dec;106(11):1596-600. doi: 10.1111/j.1464-410X.2010.09630.x. Epub 2010 Sep 14.
9
Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.前列腺癌根治术后早期辅助激素治疗的作用
J Urol. 2001 Dec;166(6):2208-15.
10
[Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer].[T3期前列腺癌根治性前列腺切除术后的肿瘤学及功能结局]
Prog Urol. 2009 May;19(5):285-90. doi: 10.1016/j.purol.2009.01.008. Epub 2009 Mar 9.

引用本文的文献

1
Vacuum therapy prevents corporeal veno-occlusive dysfunction and penile shrinkage in a cavernosal nerve injured rat model.真空疗法可预防海绵体神经损伤大鼠模型中的体静脉闭塞功能障碍和阴茎萎缩。
Asian J Androl. 2020 May-Jun;22(3):274-279. doi: 10.4103/aja.aja_57_19.
2
The correlation among the percentage of positive biopsy cores from the dominant side of prostate, adverse pathology, and biochemical failure after radical prostatectomy.前列腺癌根治术后,从优势侧前列腺活检阳性核心的百分比、不良病理和生化失败之间的相关性。
Kaohsiung J Med Sci. 2011 Aug;27(8):307-13. doi: 10.1016/j.kjms.2011.03.009. Epub 2011 May 8.
3
The role of endorectal magnetic resonance imaging in predicting extraprostatic extension and seminal vesicle invasion in clinically localized prostate cancer.
直肠内磁共振成像在预测临床局限性前列腺癌的前列腺外扩展和精囊侵犯中的作用。
Korean J Urol. 2010 May;51(5):308-12. doi: 10.4111/kju.2010.51.5.308. Epub 2010 May 19.
4
Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.根治性前列腺切除术、前列腺近距离放射治疗或外照射放疗治疗临床局限性前列腺癌两年后的生活质量:加泰罗尼亚肿瘤研究所/贝尔维奇医院的经验
Clin Transl Oncol. 2009 Jul;11(7):470-8. doi: 10.1007/s12094-009-0387-x.